GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives

Obstructive sleep apnea syndrome (OSAS) is closely associated with obesity and metabolic dysfunction. Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated superior efficacy for weight reduction and improved metabolic health compared with single GLP-1 agonists. Emerging evidence indic...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Qiujie Fang, Yipeng Zhu, Mei Rao, Peijun Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-04-01
Edice:	Frontiers in Medicine
Témata:	GLP-1/GIP dual agonist metabolic regulation obesity obstructive sleep apnea tirzepatide
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1752341/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!